Literature DB >> 7159924

Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: interaction of thrombospondin with fibronectin and collagen.

J Lahav, M A Schwartz, R O Hynes.   

Abstract

We have analyzed the interactions of platelets and platelet-secreted proteins with proteins bound to glass substrata. Using a newly developed radioactive crosslinking reagent, N-succinimidyl-3-[(2-nitro-4-azidophenyl)-2-aminoethyldithio] propionate, we observed crosslinking between thrombospondin released from the platelets and surface-bound fibronectin or collagen. The crosslinking was selective and specific, since thrombospondin showed little crosslinking to substratum-bound bovine serum albumin or ovalbumin, even though it bound to these surfaces. Furthermore, although albumin and fibrinogen released by platelets bound to fibronectin-coated substrata as well as did thrombospondin, these two proteins crosslinked at much lower levels than seen for thrombospondin. Interaction between fibronectin and thrombospondin was confirmed by affinity chromatography. These results suggest that thrombospondin and fibronectin may interact during platelet-substratum adhesion or during platelet-platelet aggregation, or both.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7159924     DOI: 10.1016/0092-8674(82)90425-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  44 in total

1.  A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion.

Authors:  M Moroi; S M Jung; M Okuma; K Shinmyozu
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

2.  Identification of Hip BMD Loss and Fracture Risk Markers Through Population-Based Serum Proteomics.

Authors:  Carrie M Nielson; Jack Wiedrick; Jian Shen; Jon Jacobs; Erin S Baker; Aaron Baraff; Paul Piehowski; Christine G Lee; Arie Baratt; Vladislav Petyuk; Shannon McWeeney; Jeong Youn Lim; Douglas C Bauer; Nancy E Lane; Peggy M Cawthon; Richard D Smith; Jodi Lapidus; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2017-04-06       Impact factor: 6.741

Review 3.  Thrombospondins in physiology and disease: new tricks for old dogs.

Authors:  Joanne E Murphy-Ullrich; Renato V Iozzo
Journal:  Matrix Biol       Date:  2012-01-12       Impact factor: 11.583

4.  A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes.

Authors:  J W Barnwell; A S Asch; R L Nachman; M Yamaya; M Aikawa; P Ingravallo
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

5.  Platelet stimulation releases a cAMP-dependent protein kinase that specifically phosphorylates a plasma protein.

Authors:  B Korc-Grodzicki; M Tauber-Finkelstein; S Shaltiel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin.

Authors:  R A Majack; S C Cook; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator.

Authors:  R L Silverstein; L L Leung; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

8.  Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.

Authors:  S Y Wong; A T Purdie; P Han
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

9.  Thrombospondin co-localises with TGF beta and IGF-I in the extracellular matrix of human osteoblast-like cells and is modulated by 17 beta estradiol.

Authors:  M Slater; J Patava; R S Mason
Journal:  Experientia       Date:  1995-03-15

10.  The interaction of Thrombospondins with extracellular matrix proteins.

Authors:  Kemin Tan; Jack Lawler
Journal:  J Cell Commun Signal       Date:  2009-10-16       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.